Company Announcement Avecho Phase III insomnia trial advances following positive interim analysis June 24, 2026June 24, 2026
Company Announcement Company Report Euroz Hartleys Initiates Research Coverage May 21, 2026June 23, 2026
Company Announcement Avecho successfully completes dosing of last patient required for Phase III interim analysis May 21, 2026June 23, 2026
Company Announcement Avecho successfully completes recruitment for interim analysis on pivotal Phase III trial March 2, 2026March 2, 2026
Company Announcement US & EU Patent Allowances for CBD Soft-Gel Formulation December 3, 2025December 3, 2025
Company Announcement Research report | RaaS Watchlist: Waking the Sleeping Giant August 26, 2025August 26, 2025
Company Announcement New Sites Commence Recruitment For Phase III Clinical Trial May 20, 2025May 21, 2025
Company Announcement Avecho receives US$3M upfront payment from Sandoz AG March 28, 2025March 28, 2025
